Microvasculature alterations of peripapillary retina and macula in systemic lupus erythematosus patients without ocular involvement by optical coherence tomography angiography

Author:

Li Huangdong1,Yu ShuiLian2,Li Peiyi2,Zhang Jingyu1,Maitiyaer Maierhaba2,Huang Amy Michelle3,Deng Qian14,Yang Ruiming1,Liang Jiamian1,Huang Wenhui2,Liu Zhiping1

Affiliation:

1. Ophthalmic Center, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China,510260

2. Department of Rheumatology, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China,510260

3. Department of Ophthalmology, University of Colorado, Aurora, CO, United States, 80045

4. Bijie Maternal and Child Health Hospital, Bijie, Guizhou,551799

Abstract

Abstract Purpose: To evaluate microvasculature alterations of the peripapillary retina (PR) and macula and to assess if the changes can detect preclinical retinopathy in systemic lupus erythematosus (SLE) patients. Methods: Cross-sectional study of 32 SLE patients without retinopathy and 22 normal controls. Optical coherence tomography angiography was used to measure the microvasculature of the PR and macula. Vessel densities (VD, %) and fractal dimensions of superficial capillary plexus (SCP) and deep capillary plexus (DCP) were calculated. Results: Compared to controls, macular VD of the whole image SCP (mVD of SCP-wi) and mVD of inferior SCP (mVD of SCP-i) were significantly reduced in SLE patients (p<0.05). The peripapillary VD (pVD) of a 2.5mm circle of SCP (pVD of SCPΦ2.5), pVD of SCPΦ3.5, and pVD of inferior region of the inner circle of SCP (pVD of SCP-ii) were significantly reduced in patients treated with hydroxychloroquine (HCQ) >5 years. mVD of SCP-wi declined with age (β=-0.12; p<0.01) and pVD of SCP-ii declined with hydroxychloroquine cumulative dose (β=-0.01; p<0.01). mVD of SCP-i had the best discrimination power of 0.77 (p<0.01). Conclusion: SLE patients without ocular involvement had microvasculature alterations that were particularly evident in the SCP. PR microvasculature may be reduced in patients with longer HCQ treatment.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3